MTNB
What one share of Matinas Biopharma Holdings holds
Pharmaceutical Preparations
Matinas Biopharma Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.19 |
|---|---|
| Cash and investments | $0.12 |
| Book value | $0.28 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $0.00 | −$10.40 | $0.00 | −$5.31 | — | $6.15 |
| 2017 | $0.08 | −$18.15 | $0.52 | −$6.85 | — | $5.72 |
| 2018 | $0.06 | −$7.64 | $0.27 | −$5.53 | — | $7.12 |
| 2019 | $0.03 | −$6.50 | $0.14 | −$4.99 | — | $10.13 |
| 2020 | $0.04 | −$5.90 | $0.00 | −$4.41 | — | $15.92 |
| 2021 | $0.01 | −$5.54 | $0.06 | −$3.68 | — | $12.14 |
| 2022 | $0.74 | −$5.00 | $0.21 | −$4.62 | — | $8.43 |
| 2023 | $0.25 | −$5.28 | $0.05 | −$3.57 | — | $4.43 |
| 2024 | — | −$4.98 | — | −$3.26 | — | $1.49 |
| 2025 | — | −$2.00 | — | −$1.28 | — | $0.75 |